CAS 1609402-14-3 appears in our catalog under these names: HA15/ 99.77% (existing batch purity), HA15, N-(4-(3-((5-(Dimethylamino)naphthalene)-1-sulfonamido)phenyl)thiazol-2-yl)acetamide, 99%, 99%, HA15, 99.98%, HA15 (Standard). Offered by: TargetMol, GLPBio, Chemat, MedChemExpress, Fluorochem. Available pack sizes: 1mg, 2mg, 5mg, 10mg, 25mg, 50mg, 100mg, 50 mg.
HA15 is a sulfonamide resulting from the formal condensation of the sulfonic acid group of 5-(dimethylamino)naphthalene-1-sulfonic acid with the aniline nitrogen of 3-(2-acetamido-1,3-thiazol-4-yl)aniline. It has been reported that by triggering an endoplasmic reticulum (ER) stress response, HA15 can reduce the viability of melanoma cells without being toxic to normal cells. It has a role as an antineoplastic agent. It is a member of acetamides, a sulfonamide, an aminonaphthalene, a member of 1,3-thiazoles, a tertiary amino compound and a biaryl.
Source: ChEBI
| Molecular formula | C23H22N4O3S2 |
|---|---|
| Molecular weight | 466.6 g/mol |
| IUPAC name | N-[4-[3-[[5-(dimethylamino)naphthalen-1-yl]sulfonylamino]phenyl]-1,3-thiazol-2-yl]acetamide |
| InChIKey | LBSMEKVVMYSTIH-UHFFFAOYSA-N |
| SMILES | CC(=O)NC1=NC(=CS1)C2=CC(=CC=C2)NS(=O)(=O)C3=CC=CC4=C3C=CC=C4N(C)C |
Computed by PubChem (NCBI)